Argitalpenak (10) Ikertzaileren baten partaidetza izan duten argitalpenak

2013

  1. Antipsychotics and seizures: Higher risk with atypicals?

    Seizure, Vol. 22, Núm. 2, pp. 141-143

  2. Comments on Duran et al.'s systematic review of anticholinergic risk scales (EJCP 2DOI 10.1007/s00228-013-1499-3)

    European Journal of Clinical Pharmacology

  3. Domperidone in Parkinson's disease: a perilous arrhythmogenic or the gold standard?

    Current drug safety, Vol. 8, Núm. 1, pp. 63-68

  4. Eosinophilia associated with bupropion

    International Journal of Clinical Pharmacy, Vol. 35, Núm. 4, pp. 532-534

  5. Expert-based drug lists to measure anticholinergic burden: Similar names, different results

    Psychogeriatrics, Vol. 13, Núm. 1, pp. 17-24

  6. Glaucoma agudo secundario a topiramato: a propósito de 2 casos

    Medicina Clinica

  7. La notificación directa por los pacientes de reacciones adversas a medicamentos en España

    Farmacia Hospitalaria, Vol. 37, Núm. 1, pp. 65-71

  8. Levofloxacin-Induced delirium in a patient suffering from schizoaffective disorder and multiple sclerosis

    Current Drug Safety, Vol. 8, Núm. 3, pp. 199-200

  9. Réquiem por el tetracepam

    Revista de Neurologia, Vol. 57, Núm. 1, pp. 1-2

  10. Serendipity, psychopharmacology and high pressure liquid chromatography

    Liquid Chromatography: Principles, Technology and Applications (Nova Science Publishers, Inc.), pp. 299-306